0 0 0 0 0 0 0 0
Thanks for submitting the form.
Stockreport

2 Reasons to Buy Regeneron Stock Like There's No Tomorrow [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
The company is also developing newer medicines that will improve its financial results. 10 stocks we like better than Regeneron Pharmaceuticals › Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there are two key reasons to think there could be plenty more upside ahead. Arguably, the biggest reason why Regeneron's shares dropped is that competition has intensified for Eylea, its medicine for wet age-related macular degeneration. Eylea's sales declined as a result. However, the biotech leader is overcoming these issues. The company's high-dose formulation of Eylea has now been on the market for about a couple of years. Its biggest selling point is that it offers a better dosing schedule -- it can be administered once every eight to 16 weeks after an initial series of starter doses. The original version is typically administered every [Read more]

IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

2 Reasons to Buy Regeneron Stock Like There's No Tomorrow [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
The company is also developing newer medicines that will improve its financial results. 10 stocks we like better than Regeneron Pharmaceuticals › Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there are two key reasons to think there could be plenty more upside ahead. Arguably, the biggest reason why Regeneron's shares dropped is that competition has intensified for Eylea, its medicine for wet age-related macular degeneration. Eylea's sales declined as a result. However, the biotech leader is overcoming these issues. The company's high-dose formulation of Eylea has now been on the market for about a couple of years. Its biggest selling point is that it offers a better dosing schedule -- it can be administered once every eight to 16 weeks after an initial series of starter doses. The original version is typically administered every [Read more]

IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS